Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ulecaciclib is an orally active, blood-brain barrier-transparent, cell cycle protein-dependent kinase (CDK) inhibitor that exhibits favorable pharmacokinetic profiles, with ki of 0.62 μM (CDK2/Cyclin A), 3 nM (CDK6/Cyclin D3), 0.2 nM (CDK4/Cyclin D1) and 0.63 μM (CDK7/Cyclin H) for CDKs. D1) and 0.63 μM (CDK7/Cyclin H).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | Ulecaciclib is an orally active, blood-brain barrier-transparent, cell cycle protein-dependent kinase (CDK) inhibitor that exhibits favorable pharmacokinetic profiles, with ki of 0.62 μM (CDK2/Cyclin A), 3 nM (CDK6/Cyclin D3), 0.2 nM (CDK4/Cyclin D1) and 0.63 μM (CDK7/Cyclin H) for CDKs. D1) and 0.63 μM (CDK7/Cyclin H). |
Molecular Weight | 496.65 |
Formula | C25H33FN8S |
Cas No. | 2075750-05-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.